Thank_You_ROCKET, keeping_our_little_light_shining:). AppreciateYa! Got_some_PR__level_news on_a_LineaRX_collaboration we_got_going_on TYME Presents Business Update and Announces Second Quarter Fiscal 2020 Conference Call and Preliminary Operational Results
We got our first alert on our "collaboration" with TYME just back on the 1st of October @THIS LINK. I like this very promising NYC cancer research group we're collaborated with through LineaRX, as much as I used to like Theracann. And, they're still on the table. Too many issues, and just blowing smoke to discuss pot. Need to pull for our business on LineaRX because:
And on Thursday, reported results of this recently completed Phase II trial using SM-88 to treat recurrent prostate cancer at the Congress of the European Society of Medical Oncology (ESMO), one of the preeminent meetings for highlighting new cancer therapies and diagnostics.
All I got for a bit.
Hoping everyone is voting. And voting YES on Proposal 2.